Page last updated: 2024-10-31

mianserin and Pancytopenia

mianserin has been researched along with Pancytopenia in 2 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Pancytopenia: Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Walder, A1
Baumann, P1
Lim, TT1
de Boer, AC1

Other Studies

2 other studies available for mianserin and Pancytopenia

ArticleYear
Cardiac left bundle branch block and pancytopenia in anorexia nervosa: higher risk with mirtazapine and pantoprazole? Case report.
    Pharmacopsychiatry, 2009, Volume: 42, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anorexia Nervosa; Anti-Ulcer Agents; Antidepressive

2009
[Pancytopenia caused by mianserin].
    Nederlands tijdschrift voor geneeskunde, 1987, Jul-04, Volume: 131, Issue:27

    Topics: Acute Kidney Injury; Aged; Female; Humans; Mianserin; Pancytopenia

1987